FBLG
FibroBiologics·NASDAQ
--
--(--)
--
--(--)
1.94 / 10
Underperform
Technical analysis is poor, with a 1.94/10 rating. Bearish candlestick shadows and a MACD death cross dominate, providing no bullish signals and suggesting further downside risk in the near term.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate37.93%
Hist. Signals87
Avg Return-1.55%
Score1/10
Win Rate37.93%
Hist. Signals87
Avg Return-1.55%
MACD Death Cross
Score1.89/10
Win Rate41.67%
Hist. Signals12
Avg Return-0.92%
Score1.89/10
Win Rate41.67%
Hist. Signals12
Avg Return-0.92%
Long Upper Shadow
Score2.94/10
Win Rate46.99%
Hist. Signals83
Avg Return0.79%
Score2.94/10
Win Rate46.99%
Hist. Signals83
Avg Return0.79%
Long Lower Shadow
Score1/10
Win Rate37.93%
Hist. Signals87
Avg Return-1.55%
Score1/10
Win Rate37.93%
Hist. Signals87
Avg Return-1.55%
Long Upper Shadow
Score2.94/10
Win Rate46.99%
Hist. Signals83
Avg Return0.79%
Score2.94/10
Win Rate46.99%
Hist. Signals83
Avg Return0.79%
MACD Death Cross
Score1.89/10
Win Rate41.67%
Hist. Signals12
Avg Return-0.92%
Score1.89/10
Win Rate41.67%
Hist. Signals12
Avg Return-0.92%
Technical Analysis of FBLG?
- FBLG presents a Underperform setup with a Technical Score of 1.94/10. Key technical indicators highlight an RSI of 41.46 and a MACD of -0.02, with the trend anchored by the 50-Day SMA at 0.31. Traders should monitor key support at 0.25 and resistance at 0.26.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
